You are here : Home > Real-time genotyping-based breast cancer risk assessment in MyPeBS, an international randomized trial in the general population comparing risk-stratified to standard breast cancer screening (BCS)

Publications CNRGH

Real-time genotyping-based breast cancer risk assessment in MyPeBS, an international randomized trial in the general population comparing risk-stratified to standard breast cancer screening (BCS)

Published on 2 October 2023
Real-time genotyping-based breast cancer risk assessment in MyPeBS, an international randomized trial in the general population comparing risk-stratified to standard breast cancer screening (BCS)
Description
 
Date de publication 
Auteurs
Delaloge S, Rossi PG, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Roman M, de Montgolfier S, Giordano L, Drubay D, Evans DG, Keatley D, Gauthier E, d'Aische AD, Baron C, Boland A, Blanche H, Couch D, Deleuze JF and Michiels S
Revue
Année2,022
Département / Service
CNRGH
Laboratoire
LBanq
Impact Factor32.98
InstitutJACOB
url DOI10.1016/j.annonc.2022.03.152

Go back to list